Gene · 3624
Papers2,354
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,354
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A CCL2+DPP4+ subset of mesenchymal stem cells expedites aberrant formation of creeping fat in humans. | Nat Commun | 2023 | 37730641 | PubTator, text mining | PubMed |
| Mechanisms of mRNA processing defects in inherited THOC6 intellectual disability syndrome. | Res Sq | 2023 | 37720017 | PubTator, text mining | PubMed |
| Dysregulation of core neurodevelopmental pathways-a common feature of cancers with perineural invasion. | Front Genet | 2023 | 37719704 | PubTator, text mining | PubMed |
| Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. | Front Genet | 2023 | 37719698 | PubTator, text mining | PubMed |
| The macrophage polarization by miRNAs and its potential role in the treatment of tumor and inflammation (Review). | Oncol Rep | 2023 | 37711048 | PubTator, text mining | PubMed |
| DMRT1 regulates human germline commitment. | Nat Cell Biol | 2023 | 37709822 | PubTator, text mining | PubMed |
| KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics. | Nat Commun | 2023 | 37709746 | PubTator, text mining | PubMed |
| Chromatin loop dynamics during cellular differentiation are associated with changes to both anchor and internal regulatory features. | Genome Res | 2023 | 37699658 | PubTator, text mining | PubMed |
| Generation of β-like cell subtypes from differentiated human induced pluripotent stem cells in 3D spheroids. | Mol Omics | 2023 | 37698079 | PubTator, text mining | PubMed |
| Dynamic changes in macrophage subtypes during lung cancer progression and metastasis at single-cell resolution. | J Thorac Dis | 2023 | 37691661 | PubTator, text mining | PubMed |
| TMT-Based Quantitative Proteomics Analysis Reveals Differentially Expressed Proteins between Different Sources of hMSCs. | Int J Mol Sci | 2023 | 37686351 | PubTator, text mining | PubMed |
| Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways. | Cells | 2023 | 37681924 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis. | Front Immunol | 2023 | 37675100 | PubTator, text mining | PubMed |
| Fucose as a nutrient ligand for Dikarya and a building block of early diverging lineages. | IMA Fungus | 2023 | 37670396 | PubTator, text mining | PubMed |
| The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis. | JCI Insight | 2023 | 37669110 | PubTator, text mining | PubMed |
| Identification of multidrug chemoresistant genes in head and neck squamous cell carcinoma cells. | Mol Cancer | 2023 | 37667354 | PubTator, text mining | PubMed |
| Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer. | Cancer Res Commun | 2023 | 37654625 | PubTator, text mining | PubMed |
| Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells. | Exp Hematol Oncol | 2023 | 37644505 | PubTator, text mining | PubMed |
| Pre-Eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools-A Review of the Literature. | Curr Issues Mol Biol | 2023 | 37623210 | PubTator, text mining | PubMed |
| The computational power of the human brain. | Front Cell Neurosci | 2023 | 37608987 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3624/papers?page=13